Evidence-based reports--is there any evidence?

PubWeight™: 1.43‹?› | Rank: Top 5%

🔗 View Article (PMID 12567335)

Published in Reg Anesth Pain Med on February 04, 2003

Authors

David L Brown

Articles citing this

Anesthesia for outpatient knee arthroscopy: is there an optimal technique? Reg Anesth Pain Med (2003) 0.83

Articles by these authors

(truncated to the top 100)

Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med (2010) 22.04

Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA (2006) 5.95

Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition). Reg Anesth Pain Med (2010) 4.77

Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials. Arch Intern Med (2012) 4.55

Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med (2012) 4.47

Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med (2003) 3.85

Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A). J Am Coll Cardiol (2012) 3.29

Vitamin B12 deficiency. Am Fam Physician (2003) 3.01

Public reporting and case selection for percutaneous coronary interventions: an analysis from two large multicenter percutaneous coronary intervention databases. J Am Coll Cardiol (2005) 3.01

A propensity analysis of the impact of platelet glycoprotein IIb/IIIa inhibitor therapy on in-hospital outcomes after percutaneous coronary intervention. Am J Cardiol (2003) 2.72

Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip or knee arthroplasty. Anesthesiology (2002) 2.07

Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med (2006) 1.97

The V-Y advancement flap is equivalent to the Mustardé flap for ectropion prevention in the reconstruction of moderate-size lid-cheek junction defects. Plast Reconstr Surg (2013) 1.94

Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials. JAMA (2005) 1.70

Risk factors for clinically relevant pulmonary embolism and deep venous thrombosis in patients undergoing primary hip or knee arthroplasty. Anesthesiology (2003) 1.60

Use of Acellular Dermal Matrix in Postmastectomy Breast Reconstruction: Are All Acellular Dermal Matrices Created Equal? Plast Reconstr Surg (2015) 1.49

Aspirin use, dose, and clinical outcomes in postmenopausal women with stable cardiovascular disease: the Women's Health Initiative Observational Study. Circ Cardiovasc Qual Outcomes (2009) 1.48

Management of patients undergoing percutaneous coronary revascularization. Ann Intern Med (2003) 1.44

The impact of advanced chronic kidney disease on in-hospital mortality following percutaneous coronary intervention for acute myocardial infarction. Catheter Cardiovasc Interv (2007) 1.42

Utility of routine functional testing after percutaneous transluminal coronary angioplasty: results from the ROSETTA registry. J Invasive Cardiol (2004) 1.40

Impact of abciximab on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction treated with primary stenting. Catheter Cardiovasc Interv (2010) 1.39

Lack of Association between Blood Pressure Management by Anesthesia Residents and Competence Committee Evaluations or In-training Exam Performance: A Cohort Analysis. Anesthesiology (2016) 1.38

Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis. Am J Med (2008) 1.37

Transapical aortic valve replacement for severe aortic stenosis: results from the nonrandomized continued access cohort of the PARTNER trial. Ann Thorac Surg (2013) 1.33

The combination of rifampin plus moxifloxacin is synergistic for suppression of resistance but antagonistic for cell kill of Mycobacterium tuberculosis as determined in a hollow-fiber infection model. MBio (2010) 1.32

The combination of meropenem and levofloxacin is synergistic with respect to both Pseudomonas aeruginosa kill rate and resistance suppression. Antimicrob Agents Chemother (2010) 1.27

Effect of inhibition of the renin-angiotensin system on development of type 2 diabetes mellitus (meta-analysis of randomized trials). Am J Cardiol (2007) 1.23

Two-surgeon technique of parenchymal transection contributes to reduced transfusion rate in patients undergoing major hepatectomy: analysis of 1,557 consecutive liver resections. Surgery (2009) 1.18

Effect of concomitant coronary artery disease on procedural and late outcomes of transcatheter aortic valve implantation. Ann Thorac Surg (2010) 1.16

Race, ethnicity, and sociocultural characteristics predict noncompliance with lipid-lowering medications. Prev Med (2004) 1.13

Myocardial engineering in vivo: formation and characterization of contractile, vascularized three-dimensional cardiac tissue. Tissue Eng (2005) 1.13

Competency in electrocardiogram interpretation among internal medicine and emergency medicine residents. Am J Med (2005) 1.13

Early sustained ventricular arrhythmias complicating acute myocardial infarction. Am J Med (2008) 1.12

Are individual differences in fatigue vulnerability related to baseline differences in cortical activation? Behav Neurosci (2005) 1.11

Neurotization improves contractile forces of tissue-engineered skeletal muscle. Tissue Eng (2007) 1.09

The impact of revascularization on mortality in patients with nonacute coronary artery disease. Am J Med (2009) 1.09

Effect of chronic obstructive pulmonary disease on survival of patients with coronary heart disease having percutaneous coronary intervention. Am J Cardiol (2004) 1.05

Design and synthesis of a novel series of N-alkyl isatin acylhydrazone derivatives that act as selective cannabinoid receptor 2 agonists for the treatment of neuropathic pain. J Med Chem (2008) 1.04

Effect of diabetes on long-term mortality following contemporary percutaneous coronary intervention: analysis of 4,284 cases. Diabetes Care (2004) 1.03

Microbial carriage state of peripheral blood dendritic cells (DCs) in chronic periodontitis influences DC differentiation, atherogenic potential. J Immunol (2012) 1.02

Tissue engineering of recellularized small-diameter vascular grafts. Tissue Eng (2005) 1.01

Resident participation does not affect surgical outcomes, despite introduction of new techniques. J Am Coll Surg (2010) 0.98

High-risk patients referred for transcatheter aortic valve implantation: management and outcomes. Ann Thorac Surg (2008) 0.95

In vitro infection model characterizing the effect of efflux pump inhibition on prevention of resistance to levofloxacin and ciprofloxacin in Streptococcus pneumoniae. Antimicrob Agents Chemother (2007) 0.94

Basosquamous carcinoma-an under-recognized, high-risk cutaneous neoplasm: case study and review of the literature. J Plast Reconstr Aesthet Surg (2006) 0.94

Suppression of central chemokine fractalkine receptor signaling alleviates amyloid-induced memory deficiency. Neurobiol Aging (2013) 0.93

Impact of spores on the comparative efficacies of five antibiotics for treatment of Bacillus anthracis in an in vitro hollow fiber pharmacodynamic model. Antimicrob Agents Chemother (2011) 0.92

Prevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor system. Anesth Analg (2012) 0.89

Influence of sex on in-hospital outcomes and long-term survival after contemporary percutaneous coronary intervention. Am Heart J (2006) 0.89

Tissue-engineered axially vascularized contractile skeletal muscle. Plast Reconstr Surg (2006) 0.89

Gender-age interaction in early mortality following primary angioplasty for acute myocardial infarction. Am J Cardiol (2006) 0.89

Increased synaptic GluR1 subunits in the anterior cingulate cortex of rats with peripheral inflammation. Eur J Pharmacol (2010) 0.89

Cardiovascular effects of ephedra alkaloids: a comprehensive review. Prog Cardiovasc Dis (2005) 0.89

Implantation increases tensile strength and collagen content of self-assembled tendon constructs. J Appl Physiol (1985) (2010) 0.88

Insulin-like growth factors and coronary heart disease. Cardiol Rev (2004) 0.88

Using an anesthesia information management system to improve case log data entry and resident workflow. Anesth Analg (2011) 0.88

Activation of the CB2 receptor system reverses amyloid-induced memory deficiency. Neurobiol Aging (2012) 0.87

Effect of peripheral arterial disease on in-hospital outcomes after primary percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol (2010) 0.87

Differential effects of linezolid and ciprofloxacin on toxin production by Bacillus anthracis in an in vitro pharmacodynamic system. Antimicrob Agents Chemother (2011) 0.87

Predicting cancer therapy-induced cardiotoxicity: the role of troponins and other markers. Drug Saf (2002) 0.86

A manual physical therapy approach versus subacromial corticosteroid injection for treatment of shoulder impingement syndrome: a protocol for a randomised clinical trial. BMJ Open (2011) 0.85

Examining the effect of a patient navigation intervention on outpatient cardiac rehabilitation awareness and enrollment. J Cardiopulm Rehabil Prev (2013) 0.85

Use of and inhospital outcomes after early clopidogrel therapy in patients not undergoing an early invasive strategy for treatment of non-ST-segment elevation myocardial infarction: results from Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association guidelines (CRUSADE). Am Heart J (2008) 0.85

Modulation of microtubule dynamics by the microtubule-associated protein 1a. J Neurosci Res (2009) 0.85

Design of potent inhibitors of human beta-secretase. Part 1. Bioorg Med Chem Lett (2006) 0.84

A strategy to prevent substance abuse in an academic anesthesiology department. J Clin Anesth (2010) 0.84

Association of health insurance status with presentation and outcomes of coronary artery disease among nonelderly adults undergoing percutaneous coronary intervention. Am Heart J (2011) 0.84

Silicon induces minimal thromboinflammatory response during 28-day intravascular implant testing. ASAIO J (2010) 0.83

Acute exertional compartment syndrome of the forearm. J Trauma (2008) 0.83

Matrix metalloproteinase inhibition with tetracyclines for the treatment of coronary artery disease. Pharmacol Res (2011) 0.82

Catastrophic hemothorax from lobar pulmonary artery puncture during attempted subclavian vein catheterization: the fallibility of venous blood aspiration. J Clin Anesth (2009) 0.82

The running shoe prescription: fit for performance. Phys Sportsmed (2005) 0.81

Impact of gender on mortality following primary angioplasty for acute myocardial infarction. Prog Cardiovasc Dis (2004) 0.81

MAP1a associated light chain 3 increases microtubule stability by suppressing microtubule dynamics. Mol Cell Neurosci (2009) 0.80

Odontogenic sinus tract to the chin: a diagnostic dilemma. Cutis (2010) 0.80

Synaptic plasticity and pain aversion. Eur J Pharmacol (2011) 0.80

Measuring outcomes of coronary artery bypass surgery: what is important and to whom? Arch Intern Med (2010) 0.80

Relation of total annual coronary angioplasty volume of physicians and hospitals on outcomes of primary angioplasty for acute myocardial infarction (data from the 1995 Coronary Angioplasty Reporting System of the New York State Department of Health). Am J Cardiol (2003) 0.80

Cutaneous furuncular myiasis: Human infestation by the botfly. Can J Plast Surg (2006) 0.80

Thrombus formation after successful stapler exclusion of the left atrial appendage. J Am Coll Cardiol (2010) 0.80

Impact of left ventricular dysfunction on hospital mortality among patients undergoing elective percutaneous coronary intervention. Am J Cardiol (2008) 0.79

Vascular disease burden and in-hospital outcomes among patients undergoing percutaneous coronary intervention in New York State. Circ Cardiovasc Interv (2009) 0.79

Design of potent inhibitors of human beta-secretase. Part 2. Bioorg Med Chem Lett (2006) 0.79

Effect of patient navigation on enrollment in cardiac rehabilitation. JAMA Intern Med (2013) 0.79

Repeated bilateral reduction mammaplasty: a 12-year experience. Plast Reconstr Surg (2010) 0.78

Comparison of event and procedure rates following percutaneous transluminal coronary angioplasty in patients with and without previous coronary artery bypass graft surgery [the ROSETTA (Routine versus Selective Exercise Treadmill Testing after Angioplasty) Registry]. Am J Cardiol (2002) 0.78

Cytoskeletal interactions of synapsin I in non-neuronal cells. Biochem Biophys Res Commun (2004) 0.78

Six-month outcomes after single- and multi-lesion percutaneous coronary intervention: results from the ROSETTA registry. Can J Cardiol (2004) 0.78

A modified method for estimating volume-outcome relationships: application to percutaneous coronary intervention. J Med Econ (2008) 0.78

Differences by age and race/ethnicity in knowledge about hypercholesterolemia. Cardiol Rev (2005) 0.78

The Relationship Between High Pulse Pressure and Low Ankle-Brachial Index. Potential Utility in Screening for Peripheral Artery Disease in Population-Based Studies. High Blood Press Cardiovasc Prev (2015) 0.78

Shared medical appointments for preoperative evaluation of symptomatic macromastia. Plast Reconstr Surg (2014) 0.77

Comparison of outcomes in acute myocardial infarction treated with coronary angioplasty alone versus coronary stent implantation. Am J Cardiol (2006) 0.77

Comparison of in-hospital outcomes following early or delayed angioplasty for acute myocardial infarction. J Invasive Cardiol (2002) 0.77

Anti-CD40L monoclonal antibody treatment induces long-term, tissue-specific, immunologic hyporesponsiveness to peripheral nerve allografts. J Reconstr Microsurg (2008) 0.77

Synthesis of tert-butyl 6-oxo-2-azaspiro[3.3]heptane-2-carboxylate. Org Lett (2009) 0.77

Comparison of three-year outcomes in blacks versus whites with coronary heart disease following percutaneous coronary intervention. Am J Cardiol (2004) 0.77

Diagnosis and monitoring of cardiac sarcoidosis with delayed-enhanced MRI and 18F-FDG PET-CT. J Nucl Cardiol (2012) 0.77

Tissue engineering of an implantable bioartificial hemofilter. ASAIO J (2007) 0.77

Mechanism and severity of mitral regurgitation by transesophageal echocardiography in patients referred for percutaneous valve repair. Am J Cardiol (2011) 0.77